Navigate Fool.com
Will AKRX beat
the market?

Akorn, Inc. (NASDAQ: AKRX)

Community Rating: 3 Stars: Appealing

34.48 -0.25 (-0.72%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $34.38
Previous Close $34.73
Daily Range $34.25 - $34.95
52-Week Range $13.43 - $37.08
Market Cap $3.6B
P/E Ratio 78.93
Dividend (Yield) $0.00 (0.0%)
Volume 549,937
Average Daily Volume 1,163,753
Current FY EPS $0.80

How do you think AKRX
will perform against the market?

Top AKRX Bull/Bear Pitches


HealthcareGuy (< 20)
Submitted December 29, 2010

Akorn, is a generic pharma company that has been remade by successful healthcare turnaround investor John Kapoor (Chariman of the Board). The major catalyst for this name, will be FDA approval of AKR … More

1 Replies Reply Report this Post

OriginalBarnacle (< 20)
Submitted August 23, 2007

P/b = 10.2 <br /><br />P/S = 12.7 <br /><br />No earnings <br /><br />Margins are worse with increasing inventory. <br /><br />Price change over 106% <br /><br />

0 Replies Reply Report this Post

News & Commentary Rss Feed

Healthcare Buyout Mania: Now What?

In less than 48 hours, investors have seen significant updates on five pharmaceutical M&A deals.

First Week of AKRX March 2015 Options Trading

First Week of AKRX July 19th Options Trading

Merck Pushes the Dow Jones Further Into Record Territory

The Dow Jones Industrial Average hit new intraday high of 17,735 today as Merck announced a deal to sell its ophthalmology business in Asia and Europe.

Jefferies Initiates Coverage on Specialty Pharmaceutical Takeover Candidates

Interesting AKRX Put And Call Options For May 17th

Ten Top Biotech Merger and Partnership Candidates

Why Akorn, Inc. Shares Were Cracked

Akorn shares tumble after the company reports its fourth-quarter earnings results. Is this dip the perfect buying opportunity or all the more reason to keep your distance?

Mid-Day Market Update: Akorn Shares Slip After Downbeat Outlook; Dendreon Gains

Mid-Morning Market Update: Markets Open Lower; Tyco To Sell South Korean Security Business For $1.93

Mid-Morning Market Update: Markets Open Lower; Tyco To Sell South Korean Security Business For $1.93B

See More AKRX News...





Akorn, Inc. (AKRX) Description

The Company manufactures and markets diagnostic and therapeutic pharmaceuticals in specialty areas such as ophthalmology, rheumatology, anesthesia and antidotes, among others. Website: http://www.akorn.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks